PGROX
Price
$68.82
Change
+$0.56 (+0.82%)
Updated
Jun 6 closing price
Net Assets
1.01B
RNPCX
Price
$65.35
Change
+$0.40 (+0.62%)
Updated
Jun 6 closing price
Net Assets
150.13B
Interact to see
Advertisement

PGROX vs RNPCX

Header iconPGROX vs RNPCX Comparison
Open Charts PGROX vs RNPCXBanner chart's image
BNY Mellon Worldwide Growth A
Price$68.82
Change+$0.56 (+0.82%)
VolumeN/A
Net Assets1.01B
American Funds New Perspective R3
Price$65.35
Change+$0.40 (+0.62%)
VolumeN/A
Net Assets150.13B
PGROX vs RNPCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PGROX vs. RNPCX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGROX is a Buy and RNPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 150B vs. PGROX (1.01B). RNPCX pays higher dividends than PGROX: RNPCX (0.24) vs PGROX (0.18). PGROX was incepted earlier than RNPCX: PGROX (32 years) vs RNPCX (23 years). PGROX (1.12) is less costly to investors than RNPCX (1.06). RNPCX is a more actively managed with annual turnover of: 24.00 vs. PGROX (13.83). RNPCX has a lower initial minimum investment than PGROX: RNPCX (250) vs PGROX (1000). RNPCX annual gain was more profitable for investors over the last year : 8.84 vs. PGROX (-6.79). RNPCX return over 5 years is better than : 41.54 vs. PGROX (25.04).
PGROXRNPCXPGROX / RNPCX
Total Expense Ratio1.121.06106%
Annual Report Gross Expense Ratio1.121.06106%
Fund Existence32 years23 years-
Gain YTD3.8308.79044%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.01B150B1%
Annual Yield % from dividends0.180.2478%
Returns for 1 year-6.798.84-77%
Returns for 3 years8.0927.7029%
Returns for 5 years25.0441.5460%
Returns for 10 years28.7274.6538%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOL1.730.04
+2.37%
Emeren Group Ltd
TIPT22.600.29
+1.30%
Tiptree
VRAX0.980.01
+0.77%
Virax Biolabs Group Limited
MYRG165.571.04
+0.63%
MYR Group
DVA137.900.16
+0.12%
DaVita